Biologics are produced through complex biological and manufacturing processes, and the resulting products may contain trace amounts of substances that are not part of the intended therapeutic or functional component. These residual impurities can originate from host cells, production reagents, purification processes, or other stages of manufacturing. Monitoring these substances is therefore an...
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek